Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01123083
Brief Title: Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2 (DEFEND-2)

First Submitted : May 11, 2010
First Submitted that Met QC Criteria : May 13, 2010
First Posted : May 14, 2010 (Estimate)

Results First Submitted : August 17, 2017
Results First Submitted that Met QC Criteria : August 17, 2017
Results First Posted : September 15, 2017

Certification/Extension First Submitted : November 15, 2012
Certification/Extension First Submitted that Met QC Criteria : November 15, 2012
Certification/Extension First Posted : November 20, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : August 17, 2017
Last Update Posted : September 15, 2017